United States· US:84826-002_33504c5f-664b-4f6b-e063-6294a90a2aea
Omlonti
A medicinal product containing omidenepag isopropyl, registered in United States by Ocuvex Therapeutics, Inc..
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- OMIDENEPAG ISOPROPYL
- Manufacturer
- Ocuvex Therapeutics, Inc.
- Country
- United States (US)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 4
- ndc1184826002011 BOTTLE, PLASTIC in 1 CARTON (84826-002-01) / 2.5 mL in 1 BOTTLE, PLASTIC
- ndc1184826002033 BOTTLE, PLASTIC in 1 CARTON (84826-002-03) / 2.5 mL in 1 BOTTLE, PLASTIC
- ndc1184826-002-01
- ndc1184826-002-03
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Omidenepag isopropyl in 1 other country
What each register calls a product with the same active substance — salts and hydrates count as the same.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/78233f3e-9637-4ef8-8b35-da1c877016e7 GET /v1/drugs/78233f3e-9637-4ef8-8b35-da1c877016e7?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "OPHTHALMIC",
"source": "ndc",
"strength": ".02",
"substance": "OMIDENEPAG ISOPROPYL",
"productndc": "84826-002",
"dosage_form": "SOLUTION/ DROPS",
"dea_schedule": null,
"strength_unit": "mg/mL",
"application_number": "NDA215092",
"marketing_category": "NDA"
}See everything about omidenepag isopropyl.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.